Who uses PacBio Revio?
Revio reads long DNA fragments with high accuracy (HiFi reads), used for whole genomes, structural variants and full-length transcripts. It's made by PacBio. 535 bioRxiv and medRxiv preprints since April 2025 say they used Revio, 195 in the last 6 months. Updated daily (as of Nov 16)
Is Revio use still growing?
Yes: 195 preprints used Revio in Jun–Nov 2026, +53% vs the previous year as a share of all preprints. This is faster than long-read sequencers overall (+16%).
The last bar is the quarter so far. The % over each year compares it with the year before, as a share of all preprints.
How does Revio compare with other long-read sequencers?
Revio is third, with 27% of their uses in Jun–Nov 2026, up from 21% the year before. PromethION leads with 40%.
Preprints in the last 6 months
PromethION285
MinION241
Revio195
Growth, Jun–Nov 2026 vs Jun–Nov 2025
PromethION+18%
MinION−5%
Revio+53%
- All long-read sequencers+16%
Which institutions use Revio most?
The institutions using Revio most are University of Washington, Arizona State University and University of California, Davis.
Institutions
University of Washington15
Arizona State University9
University of California, Davis7
Stanford University7
University of California, Berkeley6
Where the labs are
The lab's institution and country are the corresponding author's.
Rival platforms, head to head
Latest preprints using Revio
Who started using Revio recently?
95 institutions posted their first preprint using Revio since April 2025 in the last 6 months, including Kyoto University, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences and Fred Hutchinson Cancer Center.
Kyoto UniversityAug 16, 2026
Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery SciencesJun 15, 2026
Fred Hutchinson Cancer CenterJul 22, 2026
University of OregonJun 1, 2026
University of Southern CaliforniaJun 4, 2026
Gladstone InstitutesJun 4, 2026
Sungkyunkwan UniversityJun 6, 2026
University of Rome Tor VergataJun 10, 2026
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)Jun 11, 2026
Brotman Baty Institute for Precision MedicineJun 13, 2026
An institution counts as new when its first preprint using Revio since April 2025 was posted in the last 6 months; the date is that first preprint.
What do labs use alongside Revio?
Preprints using Revio most often also use NovaSeq X, PromethION and NextSeq. The count is preprints using both.
What is Revio used for?
Preprints using Revio are most often in genomics, evolutionary biology and microbiology.
Fields
Genomics 203Evolutionary biology 67Microbiology 62Genetic and genomic medicine 28Genetics 28Bioinformatics 27
Where the work was published
- G3: Genes, Genomes, Genetics9
- Nature Communications8
- Scientific Data6
- Journal of Heredity6
- Genome Biology and Evolution6
- Molecular Biology and Evolution6
How we count which preprints use each platform
An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.